Piedad, Maricel .
HRN: 07-41-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFUROXIME 500MG (TAB)
04/02/2023
04/09/2023
ORAL
500mg
BID
S/P Cesarean Section
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes